Cargando…
Effect of ASA on pituitary adenomas: is it a matter of survivin?
Autores principales: | Rotondo, Fabio, Kovacs, Kalman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642043/ https://www.ncbi.nlm.nih.gov/pubmed/31360297 http://dx.doi.org/10.18632/oncotarget.27054 |
Ejemplares similares
-
Temozolomide in aggressive pituitary adenomas and carcinomas
por: Ortiz, Leon D., et al.
Publicado: (2012) -
Progress in the Diagnosis and Classification of Pituitary Adenomas
por: Syro, Luis V., et al.
Publicado: (2015) -
Survivin overexpression is potentially associated with pituitary adenoma invasiveness
por: Kong, Xiangyi, et al.
Publicado: (2017) -
2019 ASAS Meetings
Publicado: (2019) -
Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas
por: Németh, Kinga, et al.
Publicado: (2018)